55494 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices 

Send comments to Susan G. Queen, 

Ph.D., HRSA Reports Clearance Officer, 

Room 10–33, Parklawn Building, 5600 

Fishers Lane, Rockville, MD 20857. 

Written comments should be received 

within 60 days of this notice. 

Dated: September 15, 2006. 

Cheryl R. Dammons, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. 06–8020 Filed 9–21–06; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Committee on Heritable 

Disorders and Genetic Diseases in 

Newborns and Children; Notice of 

Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Committee on Heritable 

Disorders and Genetic Diseases in Newborns 

and Children (ACHDGDNC). 

Dates and Times: November 2, 2006, 9 a.m. 

to 5 p.m. November 3, 2006, 8:30 a.m. to 3 

p.m. 

Place: Hilton Washington Hotel, 

Georgetown Room, 1919 Connecticut 

Avenue, NW., Washington, DC 20009. 

Status: The meeting will be open to the 

public with attendance limited to space 

availability. 

Purpose: The Committee was established 

specifically to advise and guide the Secretary 

regarding the most appropriate application of 

universal newborn screening tests, 

technologies, policies, guidelines and 

programs for effectively reducing morbidity 

and mortality in newborns and children 

having or at risk for heritable disorders. The 

Committee also provides advice and 

recommendations concerning the grants and 

projects authorized under the Heritable 

Disorders Program and technical information 

to develop policies and priorities for this 

program. The Heritable Disorders Program 

was established to enhance the ability of 

State and local health agencies to provide for 

newborn and child screening, counseling and 

health care services for newborns and 

children having or at risk for heritable 

disorders. 

Agenda: The meeting will include a report 

on the nomination process for newborn 

screening candidate conditions, as well as 

the continued work and reports by the 

Committee’s subcommittees on laboratory 

standards and procedures, follow-up and 

treatment, and education and training. 

Proposed agenda items are subject to 

change. 

Time will be provided each day for public 

comment. Individuals who wish to provide 

public comment or who plan to attend the 

meeting and need special assistance, such as 

sign language interpretation or other 

reasonable accommodations, should notify 

the ACHDGDNC Executive Secretary, 

Michele A. Lloyd-Puryear, M.D., Ph.D. 

(contact information provided below). 

For Further Information Contact: Anyone 

interested in obtaining a roster of members or 

other relevant information should write or 

contact Michele A. Lloyd-Puryear, M.D., 

Ph.D., Maternal and Child Health Bureau, 

Health Resources and Services 

Administration, Room 18A–19, Parklawn 

Building, 5600 Fishers Lane, Rockville, 

Maryland 20857, Telephone (301) 443–1080. 

Information on the Advisory Committee is 

available at http://mchb.hrsa.gov/programs/ 

genetics/committee. 

Dated: September 15, 2006. 

Cheryl R. Dammons, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. 06–8018 Filed 9–21–06; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Notice of Meeting of the Advisory 

Committee on Organ Transplantation 

AGENCY: Health Resources and Services 

Administration, HHS. 

SUMMARY: Pursuant to Public Law 92–

463, the Federal Advisory Committee 

Act, as amended (5 U.S.C. Appendix 2), 

notice is hereby given of the eleventh 

meeting of the Advisory Committee on 

Organ Transplantation (ACOT), 

Department of Health and Human 

Services (HHS). The meeting will be 

held from approximately 9 a.m. to 5:30 

p.m. on November 2, 2006, and from 9 

a.m. to 3 p.m. on November 3, 2006, at 

the Bethesda DoubleTree Hotel, 8120 

Wisconsin Avenue, Bethesda, MD 

20814. The meeting will be open to the 

public; however, seating is limited and 

pre-registration is encouraged (see 

below). 

SUPPLEMENTARY INFORMATION: Under the 

authority of 42 U.S.C. 217a, section 222 

of the Public Health Service Act, as 

amended, and 42 CFR 121.12 (2000), 

ACOT was established to assist the 

Secretary in enhancing organ donation, 

ensuring that the system of organ 

transplantation is grounded in the best 

available medical science, and assuring 

the public that the system is as effective 

and equitable as possible, and, thereby, 

increasing public confidence in the 

integrity and effectiveness of the 

transplantation system. ACOT is 

composed of up to 25 members, 

including the Chair. Members are 

serving as Special Government 

Employees and have diverse 

backgrounds in fields such as organ 

donation, health care public policy, 

transplantation medicine and surgery, 

critical care medicine and other medical 

specialties involved in the identification 

and referral of donors, non-physician 

transplant professions, nursing, 

epidemiology, immunology, law and 

bioethics, behavioral sciences, 

economics and statistics, as well as 

representatives of transplant candidates, 

transplant recipients, organ donors, and 

family members. 

ACOT will hear presentations on the 

revised Uniform Anatomical Gift Act; 

the United Network for Organ Sharing 

Department of Evaluation and Quality; 

the Hollywood Health and Society 

Project; new developments in 

immunosuppression; and payment for 

organs. 

The draft meeting agenda will be 

available on October 16 on the 

Department’s donation Web site at 

http://www.organdonor.gov/acot.html. 

A registration form will be available 

on October 2 on the Department’s 

donation Web site at http:// 

www.organdonor.gov/acot.html. The 

completed registration form should be 

submitted by facsimile to Professional 

and Scientific Associates (PSA), the 

logistical support contractor for the 

meeting, at fax number (703) 234–1701. 

Individuals without access to the 

Internet who wish to register may call 

Sowjanya Kotakonda with PSA at (703) 

234–1737. Registration can also be 

completed electronically at http:// 

www.psava.com/dot/acot2006/. 

Individuals who plan to attend the 

meeting and need special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should notify the ACOT Executive 

Secretary, Remy Aronoff, in advance of 

the meeting. Mr. Aronoff may be 

reached by telephone at 301–443–3264, 

e-mail: Remy.Aronoff@hrsa.hhs.gov or 

in writing at the address provided 

below. Management and support 

services for ACOT functions are 

provided by the Division of 

Transplantation, Healthcare Systems 

Bureau, Health Resources and Services 

Administration, 5600 Fishers Lane, 

Parklawn Building, Room 12C–06, 

Rockville, Maryland 20857; telephone 

number 301–443–7577. 

After the presentations and ACOT 

discussions, members of the public will 

have an opportunity to provide 

comments. Because of the Committee’s 

full agenda and the timeframe in which 

to cover the agenda topics, public 

comment will be limited. All public 


sroberts on PROD1PC70 with NOTICES